Placebo HFA

DRUG2 trials

Sponsors

GlaxoSmithKline, Boehringer Ingelheim

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 1

FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects

CompletedNCT00370097

GlaxoSmithKlineAsthma

Start: 2006-08-30End: 2007-04-12Updated: 2017-09-11

Phase 3

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

TerminatedNCT02194205

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-10-31Updated: 2014-07-18